Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06405828 · ClinicalTrials.gov registry record · NA
Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer
A NA study of Metastatic Breast Cancer and Stage IV Breast Cancer AJCC V7, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- NA
- Development phase
- 67
- Enrollment target
- 1
- Study location
NCT06405828 is a NA study of Metastatic Breast Cancer and Stage IV Breast Cancer AJCC V7 that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 67 participants, below the 204-participant average among 139 other Metastatic Breast Cancer trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06405828, a NA study of Metastatic Breast Cancer and Stage IV Breast Cancer AJCC V7, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
- 1
- Study location
Study Summary
Black and Latina women experience disparities in supportive and palliative care access and outcomes. The goal of the proposed pilot study is to evaluate the feasibility and acceptability of a community navigator delivered supportive care intervention for historically underserved populations of women with metastatic breast cancer.
Conditions Studied
Interventions
- BEHAVIORAL ACCESS Supportive Care
- BEHAVIORAL Phone sessions
Study Locations (1)
New York
- Mount Sinai Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06405828
The ClinicalTrials.gov registry entry for NCT06405828 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 204-participant average among 139 other Metastatic Breast Cancer trials with a reported enrollment target (67% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Metastatic Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which ACCESS Supportive Care is the first listed.
NCT06405828 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06405828 about?
NCT06405828 is a clinical study titled "Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer". Black and Latina women experience disparities in supportive and palliative care access and outcomes. The goal of the proposed pilot study is to evaluate the feasibility and acceptability of a community navigator delivered supportive care intervention for historically underserved populations of women...
What is the current status of trial NCT06405828?
This trial is currently recruiting. It is a NA study. The enrollment target is 67 participants. The study started on 2024-05-01. Estimated completion is 2026-11-30.
What conditions does trial NCT06405828 study?
This clinical trial studies the following conditions: Metastatic Breast Cancer, Stage IV Breast Cancer AJCC V7.
What interventions are being tested in trial NCT06405828?
The interventions under investigation include: ACCESS Supportive Care (BEHAVIORAL), Phone sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT06405828?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06405828 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer
RECRUITING · NA
-
Adaptation of a Values Assessment Tool
RECRUITING · NA
-
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
RECRUITING · NA
-
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
RECRUITING · NA
-
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
RECRUITING · NA
-
Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.